Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in OVCF after Vertebroplasty
NCT05058443Phase 3Completed
- Sponsor
- Shenzhen People's Hospital
- Start
- Jan 2020
- Primary completion
- Aug 2022
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in osteoporosis, sponsored by Shenzhen People's Hospital. Started Jan 2020; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05058443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058443.